Discover Research Beta
Browse peer-reviewed articles from Medwin Publishers' open access journals.
Showing 181–210 of 12,453 articles
Agriculture is facing increasing pressure to produce more food with fewer natural resources while adapting to climate change and environmental degradation. Water scarcity, rising…
Drug discovery is increasingly moving beyond a molecule-centered model toward approaches that place human biology, patient needs, and meaningful clinical outcomes at the center o…
Regenerative agriculture has emerged as an innovative approach to sustainable food production by focusing on restoring soil health, enhancing biodiversity, improving ecosystem fu…
The increasing demand for sustainable agricultural production has accelerated the adoption of environmentally friendly technologies that improve crop productivity while maintaini…
Artificial intelligence (AI) is changing the role of surgical robotics from mechanically precise instruments toward increasingly intelligent systems capable of recognizing anatom…
Continuous manufacturing is increasingly being recognized as an important direction for the modernization of pharmaceutical production. Unlike conventional batch manufacturing, c…
Three-dimensional (3D) printing is emerging as an innovative pharmaceutical manufacturing technology capable of producing dosage forms with customized geometry, composition, dose…
The pharmaceutical industry is entering a period of significant technological transformation. Artificial intelligence (AI), machine learning, advanced analytics, and automation a…
The Accelerated Approval pathway, established in 1992 under 21 CFR 314 Subpart H, was created to expedite patient access to promising therapeutics for serious or life-threatening…
Abstract Therapeutic innovation is entering a period in which scientific discovery is increasingly connected with data-driven development, precision medicine, real-world evidenc…
The effectiveness of a medicine in routine healthcare can differ from the efficacy demonstrated under the controlled conditions of clinical trials. This treatment-to-outcome gap …
Drug development is characterized by substantial financial investment, lengthy timelines, and high attrition rates between discovery and regulatory approval. Drug repurposing, al…
Page 7 of 416